MediPharm Labs Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEDIF research report →
About the company
MediPharm Labs Corp. operates as a pharmaceutical firm specializing in the manufacturing and distribution of pharmaceutical-grade cannabis oils, concentrates, and advanced derivative products. The company's market presence spans Canada, Australia, Germany, and other international territories.
- CEO
- David A. Pidduck
- IPO
- 2021
- Employees
- 166
- HQ
- Barrie, ON, CA
Price Chart
- Market Cap
- $21.05M
- P/E
- -3.38
- P/S
- 0.69
- P/B
- 0.85
- EV/EBITDA
- -2.82
- Div Yield
- 0.00%
- Gross Margin
- 30.63%
- Op Margin
- -20.37%
- Net Margin
- -20.21%
- ROE
- -23.55%
- ROIC
- -25.10%
- Revenue
- $45.09M · 7.45%
- Net Income
- $-8,260,262 · 22.76%
- EPS
- $-0.02 · 24.43%
- Op Income
- $-8,635,955.7
- FCF YoY
- -8.19%
- 52W High
- $0.08
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.05
- Beta
- 0.93
- Avg Volume
- 73.31K
Get TickerSpark's AI analysis on MEDIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MEDIF coverage
Recent articles, reports, and earnings notes.
No research on MEDIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MEDIF report →Similar companies
Peers in the same neighborhood.